13 results on '"Oskamp, D."'
Search Results
2. RENEB Inter-Laboratory Comparison 2021: The Gene Expression Assay
- Author
-
Abend, M., primary, Amundson, S.A., additional, Badie, C., additional, Brzoska, K., additional, Kriehuber, R., additional, Lacombe, J., additional, Lopez-Riego, M., additional, Lumniczky, K., additional, Endesfelder, D., additional, O'Brien, G., additional, Doucha-Senf, S., additional, Ghandhi, S.A., additional, Hargitai, R., additional, Kis, E., additional, Lundholm, L., additional, Oskamp, D., additional, Ostheim, P., additional, Schüle, S., additional, Schwanke, D., additional, Shuryak, I., additional, Siebenwith, C., additional, Unverricht-Yeboah, M., additional, Wojcik, A., additional, Yang, J., additional, Zenhausern, F., additional, and Port, M., additional
- Published
- 2023
- Full Text
- View/download PDF
3. RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays
- Author
-
Port, M., primary, Barquinero, J-F., additional, Endesfelder, D., additional, Moquet, J., additional, Oestreicher, U., additional, Terzoudi, G., additional, Trompier, F., additional, Vral, A., additional, Abe, Y., additional, Ainsbury, L., additional, Alkebsi, L, additional, Amundson, S.A., additional, Badie, C., additional, Baeyens, A., additional, Balajee, A.S., additional, Balázs, K., additional, Barnard, S., additional, Bassinet, C., additional, Beaton-Green, L.A., additional, Beinke, C., additional, Bobyk, L., additional, Brochard, P., additional, Brzoska, K., additional, Bucher, M., additional, Ciesielski, B., additional, Cuceu, C., additional, Discher, M., additional, D,Oca, M.C., additional, Domínguez, I., additional, Doucha-Senf, S., additional, Dumitrescu, A., additional, Duy, P.N., additional, Finot, F., additional, Garty, G., additional, Ghandhi, S.A., additional, Gregoire, E., additional, Goh, V.S.T., additional, Güçlü, I., additional, Hadjiiska, L., additional, Hargitai, R., additional, Hristova, R., additional, Ishii, K., additional, Kis, E., additional, Juniewicz, M., additional, Kriehuber, R., additional, Lacombe, J., additional, Lee, Y., additional, Lopez Riego, M., additional, Lumniczky, K., additional, Mai, T.T., additional, Maltar-Strmečki, N., additional, Marrale, M., additional, Martinez, J.S., additional, Marciniak, A., additional, Maznyk, N., additional, McKeever, S.W.S., additional, Meher, P.K., additional, Milanova, M., additional, Miura, T., additional, Monteiro Gil, O., additional, Montoro, A., additional, Moreno Domene, M., additional, Mrozik, A., additional, Nakayama, R., additional, O'Brien, G., additional, Oskamp, D., additional, Ostheim, P., additional, Pajic, J., additional, Pastor, N., additional, Patrono, C., additional, Pujol-Canadell, M., additional, Prieto Rodriguez, M.J., additional, Repin, M., additional, Romanyukha, A., additional, Rößler, U., additional, Sabatier, L., additional, Sakai, A., additional, Scherthan, H., additional, Schüle, S., additional, Seong, K.M., additional, Sevriukova, O., additional, Sholom, S., additional, Sommer, S., additional, Suto, Y., additional, Sypko, T., additional, Szatmári, T., additional, Takahashi-Sugai, M., additional, Takebayashi, K., additional, Testa, A., additional, Testard, I., additional, Tichy, A.ii A., additional, Triantopoulou, S., additional, Tsuyama, N., additional, Unverricht-Yeboah, M., additional, Valente, M., additional, Van Hoey, O., additional, Wilkins, R.C., additional, Wojcik, A., additional, Wojewodzka, M., additional, Younghyun, Lee, additional, Zafiropoulos, D., additional, and Abend, M., additional
- Published
- 2023
- Full Text
- View/download PDF
4. RENEB Inter-Laboratory Comparison 2021 : The Gene Expression Assay
- Author
-
Abend, M., Amundson, S. A., Badie, C., Brzoska, K., Kriehuber, R., Lacombe, J., López-Riego, Milagrosa, Lumniczky, K., Endesfelder, D., O'Brien, G., Doucha-Senf, S., Ghandhi, S. A., Hargitai, R., Kis, E., Lundholm, Lovisa, Oskamp, D., Ostheim, P., Schüle, S., Schwanke, D., Shuryak, I., Siebenwith, C., Unverricht-Yeboah, M., Wojcik, Andrzej, Yang, J., Zenhausern, F., Port, M., Abend, M., Amundson, S. A., Badie, C., Brzoska, K., Kriehuber, R., Lacombe, J., López-Riego, Milagrosa, Lumniczky, K., Endesfelder, D., O'Brien, G., Doucha-Senf, S., Ghandhi, S. A., Hargitai, R., Kis, E., Lundholm, Lovisa, Oskamp, D., Ostheim, P., Schüle, S., Schwanke, D., Shuryak, I., Siebenwith, C., Unverricht-Yeboah, M., Wojcik, Andrzej, Yang, J., Zenhausern, F., and Port, M.
- Abstract
Early and high-throughput individual dose estimates are essential following large-scale radiation exposure events. In the context of the Running the European Network for Biodosimetry and Physical Dosimetry (RENEB) 2021 exercise, gene expression assays were conducted and their corresponding performance for dose-assessment is presented in this publication. Three blinded, coded whole blood samples from healthy donors were exposed to 0, 1.2 and 3.5 Gy X-ray doses (240 kVp, 1 Gy/min) using the X-ray source Yxlon. These exposures correspond to clinically relevant groups of unexposed, low dose (no severe acute health effects expected) and high dose exposed individuals (requiring early intensive medical health care). Samples were sent to eight teams for dose estimation and identification of clinically relevant groups. For quantitative reverse transcription polymerase chain reaction (qRT-PCR) and microarray analyses, samples were lysed, stored at 20°C and shipped on wet ice. RNA isolations and assays were run in each laboratory according to locally established protocols. The time-to-result for both rough early and more precise later reports has been documented where possible. Accuracy of dose estimates was calculated as the difference between estimated and reference doses for all doses (summed absolute difference, SAD) and by determining the number of correctly reported dose estimates that were defined as ±0.5 Gy for reference doses <2.5 Gy and ±1.0 Gy for reference doses >3 Gy, as recommended for triage dosimetry. We also examined the allocation of dose estimates to clinically/diagnostically relevant exposure groups. Altogether, 105 dose estimates were reported by the eight teams, and the earliest report times on dose categories and estimates were 5 h and 9 h, respectively. The coefficient of variation for 85% of all 436 qRT-PCR measurements did not exceed 10%. One team reported dose estimates that systematically deviated several-fold from reported dose estimates, and
- Published
- 2023
- Full Text
- View/download PDF
5. Examining Radiation-Induced In Vivo and In Vitro Gene Expression Changes of the Peripheral Blood in Different Laboratories for Biodosimetry Purposes: First RENEB Gene Expression Study
- Author
-
Abend, M., Badie, C., Quintens, R., Kriehuber, R., Manning, G., Macaeva, E., Njima, M., Oskamp, D., Strunz, S., Moertl, S., Doucha-Senf, S., Dahlke, S., Menzel, J., and Port, M.
- Published
- 2016
6. Early response of lymphocyte proteins after gamma-radiation
- Author
-
Turtoi, A., Srivastava, A., Sharan, R. N., Oskamp, D., Hille, R., and Schneeweiss, F. H. A.
- Published
- 2007
- Full Text
- View/download PDF
7. Early gene expression in human lymphocytes aftergamma-irradiation–a genetic pattern with potential for biodosimetry
- Author
-
Turtoi, A., primary, Brown, I., additional, Oskamp, D., additional, and Schneeweiss, F. H. A., additional
- Published
- 2008
- Full Text
- View/download PDF
8. Early gene expression in human lymphocytes after γ-irradiation-a genetic pattern with potential for biodosimetry.
- Author
-
Turtoi, A., Brown, I., Oskamp, D., and Schneeweiss, F. H. A.
- Subjects
LYMPHOCYTES ,GENE expression ,RADIATION dosimetry ,POLYMERASE chain reaction ,IRRADIATION ,TUMOR necrosis factors - Abstract
Purpose: Identification of early radiation response genes (ERG) in human lymphocytes after γ-irradiation by using the whole-human-genome DNA-microarrays and the evaluation of their possible role in rapid radiation biodosimetry by applying real-time quantitative polymerase chain reaction (RT-qPCR) methodology for validation in a small group of human individuals. Materials and methods: Whole blood from a healthy human donor was exposed at 37°C to 137Cs γ-radiations (absorbed dose: 1-4 Gy). Fifteen minutes following irradiation the lymphocytes were isolated from the blood (for 2 h at 20°C) and their gene expression was investigated using the DNA-microarrays. Subsequently, 14 genes were selected and validated using the TaqMan™ probes based upon the RT-qPCR assay within a group of 6 human donors. Results: A dose-related relative change in quantitative gene expression using the DNA-microarray assay was demonstrated in 24 of 102 genes. Up-regulation of expression was observed in 15 genes: CD69 (CD69 molecule), CDKN1A (cyclin-dependent kinase inhibitor 1A), EGR1 (early growth response 1), EGR4 (early growth response 4), FLJ35725 (chromosome 4 ORF 23), hCG2041177 (hCG - human Celera® Genome), hCG1643466.2, IFN-γ (interferon-γ), ISG20L (interferon stimulated exonuclease gene 20 kDa - like 1), c-JUN (jun oncogene), MDM2 (mouse double minute 2), MUC5B (mucine), PLK2 (polo-like kinase 2), RND1 (rho-family GTPase 1) and TNFSF9 (tumour necrosis factor superfamily member 9). Down-regulation of expression was found in the remaining nine genes: GRIK3 (glutamate receptor ionotropic kainate 3), hCG1985174, hCG1998530, hCG2038519, OCLN (occludin), RPL10A (ribosomal protein L10a), SERHL2 (serine hydrolase-like 2), SGK3 (serum/glucocorticoid regulated kinase 3) and STARD13 (START domain containing 13). Conclusion: A significant correlation between absorbed radiation dose and change in relative gene expression was particularly evident for EGR1, EGR4, IFN-γ, c-JUN and TNFSF9 (p ≤ 0.05). Results warrant the further investigation of these ERG as potential biodosimetric markers. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
9. Comparable dose estimates of blinded whole blood samples are obtained independently of culture conditions and analytical approaches. Second RENEB gene expression study.
- Author
-
Manning G, Macaeva E, Majewski M, Kriehuber R, Brzóska K, Abend M, Doucha-Senf S, Oskamp D, Strunz S, Quintens R, Port M, and Badie C
- Subjects
- Blood Chemical Analysis methods, Europe, Radiation Dosage, Reproducibility of Results, Sensitivity and Specificity, Single-Blind Method, Biological Assay methods, Blood Proteins analysis, Blood Specimen Collection methods, Gene Expression Profiling methods, Radiation Exposure analysis, Radiation Monitoring methods
- Abstract
Purpose: This collaboration of five established European gene expression labs investigated the potential impact of culture conditions on the transcriptional response of peripheral blood to radiation exposure., Materials and Methods: Blood from one healthy donor was exposed ex vivo to a Cobalt 60 source to produce a calibration curve in addition to four unknown doses. After exposure, the blood samples were either diluted with RPMI medium or left untouched. After 24-h incubation at 37 °C the diluted blood samples were lysed, while the undiluted samples were mixed with the preservative RNALater and all samples were shipped frozen to the participating labs. Samples were processed by each lab using microarray (one lab) and QRT-PCR (four labs)., Results: We show that although culture conditions affect the total amount of RNA recovered (p < .0001) and its integrity (p < .0001), it does not significantly affect dose estimates (except for the true dose at 1.1 Gy). Most importantly, the different analysis approaches provide comparable mean absolute difference of estimated doses relative to the true doses (p = .9) and number of out of range (>0.5 Gy) measurements (p = .6)., Conclusion: This study confirms the robustness of gene expression as a method for biological dosimetry.
- Published
- 2017
- Full Text
- View/download PDF
10. Integration of new biological and physical retrospective dosimetry methods into EU emergency response plans - joint RENEB and EURADOS inter-laboratory comparisons.
- Author
-
Ainsbury E, Badie C, Barnard S, Manning G, Moquet J, Abend M, Antunes AC, Barrios L, Bassinet C, Beinke C, Bortolin E, Bossin L, Bricknell C, Brzoska K, Buraczewska I, Castaño CH, Čemusová Z, Christiansson M, Cordero SM, Cosler G, Monaca SD, Desangles F, Discher M, Dominguez I, Doucha-Senf S, Eakins J, Fattibene P, Filippi S, Frenzel M, Georgieva D, Gregoire E, Guogyte K, Hadjidekova V, Hadjiiska L, Hristova R, Karakosta M, Kis E, Kriehuber R, Lee J, Lloyd D, Lumniczky K, Lyng F, Macaeva E, Majewski M, Vanda Martins S, McKeever SW, Meade A, Medipally D, Meschini R, M'kacher R, Gil OM, Montero A, Moreno M, Noditi M, Oestreicher U, Oskamp D, Palitti F, Palma V, Pantelias G, Pateux J, Patrono C, Pepe G, Port M, Prieto MJ, Quattrini MC, Quintens R, Ricoul M, Roy L, Sabatier L, Sebastià N, Sholom S, Sommer S, Staynova A, Strunz S, Terzoudi G, Testa A, Trompier F, Valente M, Hoey OV, Veronese I, Wojcik A, and Woda C
- Subjects
- European Union, Reproducibility of Results, Retrospective Studies, Sensitivity and Specificity, Systems Integration, Biological Assay methods, Disaster Planning methods, Laboratories, Radiation Exposure analysis, Radiation Monitoring methods, Safety Management methods
- Abstract
Purpose: RENEB, 'Realising the European Network of Biodosimetry and Physical Retrospective Dosimetry,' is a network for research and emergency response mutual assistance in biodosimetry within the EU. Within this extremely active network, a number of new dosimetry methods have recently been proposed or developed. There is a requirement to test and/or validate these candidate techniques and inter-comparison exercises are a well-established method for such validation., Materials and Methods: The authors present details of inter-comparisons of four such new methods: dicentric chromosome analysis including telomere and centromere staining; the gene expression assay carried out in whole blood; Raman spectroscopy on blood lymphocytes, and detection of radiation-induced thermoluminescent signals in glass screens taken from mobile phones., Results: In general the results show good agreement between the laboratories and methods within the expected levels of uncertainty, and thus demonstrate that there is a lot of potential for each of the candidate techniques., Conclusions: Further work is required before the new methods can be included within the suite of reliable dosimetry methods for use by RENEB partners and others in routine and emergency response scenarios.
- Published
- 2017
- Full Text
- View/download PDF
11. Corrigendum to "Chromosome aberrations induced by the Auger electron emitter (125)I" [Mut. Res.-Genet. Toxicol. Environ. Mutagen. 793 (2015) 64-70].
- Author
-
Schmitz S, Oskamp D, Pomplun E, and Kriehuber R
- Published
- 2016
- Full Text
- View/download PDF
12. Chromosome aberrations induced by the Auger electron emitter (125)I.
- Author
-
Schmitz S, Oskamp D, Pomplun E, and Kriehuber R
- Subjects
- Cell Culture Techniques, Cell Proliferation radiation effects, DNA Breaks, Double-Stranded, Dose-Response Relationship, Radiation, Humans, Male, Relative Biological Effectiveness, Chromosome Aberrations, DNA radiation effects, Iodine Radioisotopes pharmacokinetics, Lymphocytes radiation effects
- Abstract
DNA-associated Auger electron emitters (AEE) cause cellular damage leading to high-LET type cell survival curves indicating an enhanced relative biological effectiveness. Double strand breaks (DSBs) induced by Iodine-125-deoxyuridine ((125)I-UdR) decays are claimed to be very complex. To elucidate the assumed genotoxic potential of (125)I-UdR, chromatid aberrations were analysed in exposed human peripheral blood lymphocytes (PBL). PBL were stimulated with medium containing phytohaemagglutinin (PHA). After 24h, cultures were labelled with (125)I-UdR for 18h (activity concentration 1-45 kBq) during the S-phase. Following standard cytogenetic procedure, at least 100 metaphases were analysed microscopically for each activity concentration. Cell death was measured by apoptosis assay using flow cytometry. Radiation doses were determined by using point kernel calculations. After 18h labelling with (125)I-UdR the cell cycle distribution is severely disturbed. About 40% of PBL are fully labelled and 20% show a moderate labelling of (125)I-UdR, whereas 40% of cells remain un-labelled. The dose-response relationship fits to a polynomial curve in the low dose range, whereas a linear fit supplies a better estimation in the high dose range. Even the lowest dose of 0.2Gy leads to a 13-fold increase of aberrations compared to the controls. On average every fifth (125)I-decay produces a single chromatid aberration in PBL. Additionally, a dose-dependent increase of cell death is observed. (125)I-UdR has a very strong genotoxic capacity in human PBL, even at 0.2Gy. Efficiently labelled cells displaying a prolonged cell cycle compared to moderately labelled cells and cell death contribute substantially to the desynchronisation of the cell cycle. Our data, showing for the first time, that one (125)I-decay induces ∼ 0.2 chromatid aberrations, are in very good accordance to DSB data, stating that ∼0.26 DSB are induced per decay, indicating that it takes on average 250 decays to induce one chromosome aberration (CA). [Corrected], (Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
13. Early gene expression in human lymphocytes after gamma-irradiation-a genetic pattern with potential for biodosimetry.
- Author
-
Turtoi A, Brown I, Oskamp D, and Schneeweiss FH
- Subjects
- Cell Proliferation, Dose-Response Relationship, Radiation, Female, Humans, Lymphocytes radiation effects, Male, Oligonucleotide Array Sequence Analysis, RNA, Messenger metabolism, Radiation, Ionizing, Time Factors, Transcription Factors metabolism, Gamma Rays, Gene Expression Profiling, Gene Expression Regulation radiation effects, Lymphocytes metabolism, Radiometry methods
- Abstract
Purpose: Identification of early radiation response genes (ERG) in human lymphocytes after gamma-irradiation by using the whole-human-genome DNA-microarrays and the evaluation of their possible role in rapid radiation biodosimetry by applying real-time quantitative polymerase chain reaction (RT-qPCR) methodology for validation in a small group of human individuals., Materials and Methods: Whole blood from a healthy human donor was exposed at 37 degrees C to 137Cs gamma-radiations (absorbed dose: 1-4 Gy). Fifteen minutes following irradiation the lymphocytes were isolated from the blood (for 2 h at 20 degrees C) and their gene expression was investigated using the DNA-microarrays. Subsequently, 14 genes were selected and validated using the TaqMan probes based upon the RT-qPCR assay within a group of 6 human donors., Results: A dose-related relative change in quantitative gene expression using the DNA-microarray assay was demonstrated in 24 of 102 genes. Up-regulation of expression was observed in 15 genes: CD69 (CD69 molecule), CDKN1A (cyclin-dependent kinase inhibitor 1A), EGR1 (early growth response 1), EGR4 (early growth response 4), FLJ35725 (chromosome 4 ORF 23), hCG2041177 (hCG - human Celera Genome), hCG1643466.2, IFN-gamma (interferon-gamma), ISG20L (interferon stimulated exonuclease gene 20 kDa - like 1), c-JUN (jun oncogene), MDM2 (mouse double minute 2), MUC5B (mucine), PLK2 (polo-like kinase 2), RND1 (rho-family GTPase 1) and TNFSF9 (tumour necrosis factor superfamily member 9). Down-regulation of expression was found in the remaining nine genes: GRIK3 (glutamate receptor ionotropic kainate 3), hCG1985174, hCG1998530, hCG2038519, OCLN (occludin), RPL10A (ribosomal protein L10a), SERHL2 (serine hydrolase-like 2), SGK3 (serum/glucocorticoid regulated kinase 3) and STARD13 (START domain containing 13)., Conclusion: A significant correlation between absorbed radiation dose and change in relative gene expression was particularly evident for EGR1, EGR4, IFN-gamma, c-JUN and TNFSF9 (p < or = 0.05). Results warrant the further investigation of these ERG as potential biodosimetric markers.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.